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Multidisciplinary research priorities for the COVID-19 
pandemic: a call for action for mental health science
Emily A Holmes*, Rory C O’Connor*, V Hugh Perry, Irene Tracey, Simon Wessely, Louise Arseneault, Clive Ballard, Helen Christensen, 
Roxane Cohen Silver, Ian Everall, Tamsin Ford, Ann John, Thomas Kabir, Kate King, Ira Madan, Susan Michie, Andrew K Przybylski, Roz Shafran, 
Angela Sweeney, Carol M Worthman, Lucy Yardley, Katherine Cowan, Claire Cope, Matthew Hotopf†, Ed Bullmore†
The coronavirus disease 2019 (COVID-19) pandemic is having a profound effect on all aspects of society, including 
mental health and physical health. We explore the psychological, social, and neuroscientific effects of COVID-19 and 
set out the immediate priorities and longer-term strategies for mental health science research. These priorities were 
informed by surveys of the public and an expert panel convened by the UK Academy of Medical Sciences and the 
mental health research charity, MQ: Transforming Mental Health, in the first weeks of the pandemic in the UK in 
March, 2020. We urge UK research funding agencies to work with researchers, people with lived experience, and 
others to establish a high level coordination group to ensure that these research priorities are addressed, and to allow 
new ones to be identified over time. The need to maintain high-quality research standards is imperative. International 
collaboration and a global perspective will be beneficial. An immediate priority is collecting high-quality data on the 
mental health effects of the COVID-19 pandemic across the whole population and vulnerable groups, and on brain 
function, cognition, and mental health of patients with COVID-19. There is an urgent need for research to address 
how mental health consequences for vulnerable groups can be mitigated under pandemic conditions, and on the 
impact of repeated media consumption and health messaging around COVID-19. Discovery, evaluation, and 
refinement of mechanistically driven interventions to address the psychological, social, and neuroscientific aspects of 
the pandemic are required. Rising to this challenge will require integration across disciplines and sectors, and should 
be done together with people with lived experience. New funding will be required to meet these priorities, and it can 
be efficiently leveraged by the UK’s world-leading infrastructure. This Position Paper provides a strategy that may be 
both adapted for, and integrated with, research efforts in other countries.
Introduction
It is already evident that the direct and indirect 
psychological and social effects of the coronavirus disease 
2019 (COVID-19) pandemic are pervasive and could affect 
mental health now and in the future. The pandemic is 
occurring against the backdrop of increased prevalence of 
mental health issues in the UK in recent years in 
some groups.1,2 Furthermore, severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), the virus that 
causes COVID-19, might infect the brain or trigger 
immune responses that have additional adverse effects 
on brain function and mental health in patients with 
COVID-19.
Research funders and researchers must deploy resources 
to understand the psychological, social, and neuroscientific 
effects of the COVID-19 pandemic. Mob ilisation now will 
allow us to apply the learnings gained to any future periods 
of increased infection and lockdown, which will be 
particularly important for front-line workers and for 
vulnerable groups, and to future pandemics. We propose a 
framework for the prioritisation and coordination of 
essential, policy-relevant psychological, social, and 
neuroscientific research, to ensure that any investment is 
efficiently targeted to the crucial mental health science 
questions as the pandemic unfolds. We use the term 
mental health sciences to reflect the many different 
disciplines, including, but not limited to, psychology, 
psychiatry, clinical medicine, behavioural and social 
sciences, and neuroscience, that will need to work together 
in a multidisciplinary fashion together with people with 
lived experience of mental health issues or COVID-19 to 
address these research priorities.
The UK has powerful advantages in mounting a 
successful response to the pandemic, including strong 
existing research infrastructure and expertise, but the 
research community must act rapidly and collaboratively 
if it is to deal with the growing threats to mental health. 
A fragmented research response, characterised by small-
scale and localised initiatives, will not yield the clear 
insights necessary to guide policy makers or the public. 
Rigorous scientific and ethical review of protocols and 
results remains the cornerstone of safeguarding patients 
and upholding research standards. Deploying a mental 
health science perspective3 to the pandemic will also 
inform population-level behaviour change initiatives 
aimed at reducing the spread of the virus. International 
comparisons will be especially helpful in this regard. In 
this Position Paper, we explore the psychological, social, 
and neuroscientific effects of COVID-19 and set out clear 
immediate priorities and longer-term strategies for each 
of these aspects.
We also surveyed the public and people with lived 
experience of mental ill-health (panel 1). The general 
population survey, done by Ipsos MORI,4 revealed 
widespread concerns about the effect of social isolation 
or social distancing on wellbeing; increased anxiety, 
depression, stress, and other negative feelings; and 
concern about the practical implications of the pandemic 
response, including financial difficulties. The prospect of 
becoming physically unwell with COVID-19 ranked 
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lower than these issues related to the social and 
psychological response to the pandemic. The MQ: 
Transforming Mental Health stakeholder survey of 
people with lived experience of a mental health issue 
likewise highlighted general concerns about social 
isolation and increased feelings of anxiety and 
depression. More specifically, stakeholders frequently 
expressed concerns about exacerbation of pre-existing 
mental health issues, greater difficulty in accessing 
mental health support and services under pandemic 
conditions, and the effect of COVID-19 on the mental 
health of family members, especially children and older 
people. Both surveys are reported online.4 These findings, 
combined with the published scientific literature, 
informed the development of our research priorities. The 
surveys represent a snapshot of the current situation, but 
they will need to be repeated more rigorously over the 
course of the pandemic, and the research priorities 
reviewed.
Psychology and individual factors: researching 
the effect of COVID-19 on mental health
In this section, we focus on the psychological processes 
and effects in individual people related to COVID-19, 
such as cognition, emotion, and behaviour, that affect 
mental health (table 1).
What is the effect of COVID-19 on risk of anxiety, 
depression, and other outcomes, such as self-harm and 
suicide?
Although a rise in symptoms of anxiety and coping 
responses to stress are expected during these extraordinary 
circumstances, there is a risk that prevalence of clinically 
relevant numbers of people with anxiety, depression, and 
engaging in harmful behaviours (such as suicide and self-
harm) will increase. Of note, however, is that a rise in 
suicide is not inevitable, especially with national 
mitigation efforts.17
The potential fallout of an economic downturn on 
mental health is likely to be profound on those directly 
affected and their caregivers. The severe acute respiratory 
syndrome epidemic in 2003 was associated with a 30% 
increase in suicide in those aged 65 years and older; 
around 50% of recovered patients remained anxious; and 
29% of health-care workers experienced probable 
emotional distress.18–20 Patients who survived severe and 
life-threatening illness were at risk of post-traumatic 
stress disorder and depression.19,20 Many of the anticipated 
consequences of quarantine14 and associated social and 
physical distancing measures are themselves key risk 
factors for mental health issues. These include suicide 
and self-harm, alcohol and substance misuse, gambling, 
domestic and child abuse, and psychosocial risks (such 
as social disconnection, lack of meaning or anomie, 
entrapment, cyberbullying, feeling a burden, financial 
stress, bereavement, loss, unemployment, homelessness, 
and relationship breakdown).21–23
A major adverse consequence of the COVID-19 
pandemic is likely to be increased social isolation and 
loneliness (as reflected in our surveys),4 which are 
strongly associated with anxiety, depression, self-harm, 
and suicide attempts across the lifespan.24,25 Tracking 
loneliness and intervening early are important priorities. 
Crucially, reducing sustained feelings of loneliness and 
promoting belongingness are candidate mechanisms to 
protect against suicide, self-harm, and emotional 
Panel 1: Methodology
This Position Paper summarises the priorities put forward by an interdisciplinary group of 
24 world-leading experts, including people with lived experience of a mental health issue, 
from across the bio-psycho-social spectrum of expertise in mental health science in March 
and April, 2020. The experts were convened by the UK Academy of Medical Sciences and 
the mental health research charity, MQ: Transforming Mental Health. Members 
participated in an individual capacity, not as representatives of their organisations. 
A coordinating group of seven experts met daily over a period of two weeks to develop 
the research priorities, informed by input from the expert advisory group. Given the need 
to develop the research priorities rapidly to inform immediate funding priorities, 
extended evidence gathering and consultation was not possible. However, we are 
confident that the wide breadth of expertise on the expert group and their leading roles in 
their respective fields provide a wide-ranging and comprehensive view of the mental 
health and neuroscience research priorities now; priorities which should be reviewed and 
should evolve with the pandemic.
Lived experience of a mental health issue was incorporated by four mechanisms. First, 
three representatives with lived experience provided input as part of the expert advisory 
group. Second, an online survey collected data on people’s two biggest concerns about 
the mental health and wellbeing implications of the coronavirus disease 2019 (COVID-19) 
pandemic and the coping strategies used by patients. The survey was promoted via email 
to MQ’s supporter network and via social media. In total, 2198 people completed the 
survey, submitting 4350 concerns about the mental health effects of the COVID-19 
pandemic and 1987 responses about what has helped to maintain mental health and 
wellbeing during the pandemic. A thematic analysis of the full dataset was done. Third, 
two questions were asked on Ipsos MORI’s online Omnibus survey to collect data on 
people’s concerns about the effect of COVID-19 on mental wellbeing and what is helping 
people’s mental wellbeing at this time. In total, 1099 interviews were completed with 
adults aged between 16 and 75 years from across England, Wales, and Scotland. Quotas 
were set and data were weighted to the offline population to ensure a nationally 
representative sample by gender, age, and region. Statistical analysis was done and any 
subgroup differences included are statistically significant at a 95% confidence interval 
unless stated otherwise. A summary report of the findings of both surveys and further 
methodological details can be found online.4 The Ipsos MORI tabular data can be found on 
its website.5 Finally, the manuscript was peer-reviewed by a reviewer with lived experience 
of a mental health issue. We acknowledge the limitations of our surveys, including the 
representativeness of the MQ sample, the short timescale for input, and the 
representativeness of online populations. We also acknowledge the restricted evidence 
gathering and opportunity for wider consultation of people with lived experience. 
However, combined, these four mechanisms of collecting input from people with lived 
experience provide important insight into people’s concerns about the effect of COVID-19 
on mental health and coping strategies within the very short timeframe.
A living systematic map6 is tracking emerging empirical studies, systematic reviews, and 
modelling on COVID-19. As of April 1, 2020, 643 records were identified in the databases 
MEDLINE and Embase. Only ten of these were on mental health effects of the pandemic.7–16
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problems.26,27 Social isolation and loneliness are distinct 
and might represent different risk pathways.
To inform management of COVID-19, it is vital to 
understand the socioeconomic effect of the policies used 
to manage the pandemic, which will inevitably have 
serious effects on mental health by increasing 
unemployment, financial insecurity, and poverty.28,29 
Involvement of people with lived experience and rapid 
qualitative research with diverse people and communities 
will help to identify ways in which this negative effect 
might be alleviated. Achieving the right balance between 
infection control and mitigation of these negative 
socioeconomic effects must be considered.30
The immediate research priorities are to monitor and 
report rates of anxiety, depression, self-harm, suicide, and 
other mental health issues both to understand 
mechanisms and crucially to inform interventions. This 
should be adopted across the general population and 
vulnerable groups, including front-line workers. 
Monitoring must go beyond NHS record linkage to 
capture the real incidence in the community, because 
self-harm might become more hidden. We must harness 
existing datasets and ongoing longitudinal studies, and 
establish new cohorts with new ways of recording 
including detailed psychological factors.26,31 Techniques 
assessing moment to moment changes in psychological 
risk factors should be embraced.
Given the unique circumstances of COVID-19, data will 
be vital to determine causal mechanisms associated with 
poor mental health,31,32 including loneliness and 
entrapment. To optimise effectiveness of psychological 
treatments, they need to be mechanistically informed—
that is, targeting factors which are both causally associated 
with poor mental health and modifiable by an 
intervention.31 A one-size-fits-all response will not suffice 
because the effectiveness of interventions can vary across 
groups.26,33–36 Digital psychological interventions that are 
mechanistically informed, alongside better understanding 
of the buffering effects of social relationships during 
stressful events, are required in the long term. The digital 
response is crucial,37–39 not only because of social isolation 
measures but also because less than a third of people who 
die by suicide have been in contact with mental health 
services in the 12 months before death.40 Digital inter-
ventions for anxiety, depression, self-harm, and suicide 
include information provision, connectivity and triage, 
automated and blended therapeutic interventions (such 
as apps and online programmes), telephone calls and 
messages to reach those with poorer digital resources 
(digital poverty),41 suicide risk assessments, chatlines and 
forums, and technologies that can be used to monitor risk 
either passively or actively. The digital landscape extends 
beyond apps and requires an evidence base. Artificial 
intelligence-driven adaptive trials could help to evaluate 
effectiveness, while digital phenotyping could be helpful 
to ascertain early warning signs for mental ill-health.42
Looking beyond digital interventions (as not everyone 
has access to them), and ascertaining what other mechan-
istically based psychological interventions are effective 
and for whom is important.31,43 Risks and buffers for 
loneliness should be a focal target in interventions to 
protect wellbeing. The longer-term consequences of 
COVID-19 for the younger and older generations (and 
other groups at high risk, including workers, those with 
existing mental health conditions, and caregivers) are 
also unknown and must be a priority.
How do individuals build optimal structures for a 
mentally healthy life that works for them in the wake of 
COVID-19 and social and physical distancing? 
The optimal structure of a mentally healthy life for 
individuals in the wake of COVID-19 needs to be 
mapped out. Structure will vary as a function of 
background and individual circumstances. Changes in 
sleep and lifestyle behaviours influence our mental 
health and stress response. Understanding the effective, 
individualised ways of coping in such a situation is of 
paramount importance.44–46 The social and personal 
resources (eg, seeing family and getting sufficient sleep) 
available to individuals can be important resilience-
related factors for mitigating mental health difficulties 
under particularly stressful circumstances.47 We need 
Immediate actions Longer-term strategic programmes
What is the effect of 
COVID-19 on risk of anxiety, 
depression, and other 
outcomes, such as self-harm 
and suicide?
Improve monitoring and reporting of the rates of 
anxiety, depression, self-harm, suicide, and other 
mental health issues; determine the efficacy of 
mechanistically based digital and non-digital 
interventions and evaluate optimal model(s) of 
implementation
Determine the mechanisms (eg, entrapment and loneliness) that 
explain the rates of anxiety, depression, self-harm, and suicide; 
understand the role of psychological factors in buffering the effect of 
social context on mental health issues; ascertain the longer-term 
consequences on wellbeing of COVID-19 for the young and older 
generations (and vulnerable groups)
What is the optimal structure 
for a mentally healthy life in 
the wake of COVID-19 and 
social or physical distancing?
Determine what psychological support is available to 
help front-line medical and health-care staff and 
their families; understand the psychological 
(eg, coping), physiological (eg, sleep and nutrition), 
and structural (eg, work rotas and daily routines) 
factors that protect or adversely affect mental health
Develop novel interventions to protect mental wellbeing, including 
those based on positive mechanistically based components, such as 
altruism and prosocial behaviour and understanding of online life; 
understand how we optimise positive social resources and enhance 
resilience in the face of stress; establish the effects of altruism on mental 
health and wellbeing in the wake of COVID-19
COVID-19=coronavirus disease 2019.
Table 1: Psychology and individual factors: the effect of COVID-19 on mental health
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research to foster positive social resources, resilience, 
and altruism.
The immediate research priorities are to understand 
how front-line health and social care staff and their families 
can be supported to optimise coping strategies to mitigate 
symptoms of stress, and facilitate the imple mentation of 
preventive interventions in the future.14,48 During the 
COVID-19 pandemic, it is important that health and social 
care workers are supported to stay in work, the health, 
personal, social, and economic benefits of which are vast. 
Personalised psychological approaches are likely to be a 
key component to address complex mental health 
conditions, coping mechanisms, and prevention.31 Given 
the association between sleep disturbance and mental 
health,49 and the effect of sleep disturbance on the risk of 
suicide,50 research on mitigating the effect of such changes 
on mental health and stress response is required.
The longer-term strategic research programmes are to 
develop novel interventions to protect mental wellbeing, 
including those based on positive mechanistically based 
components (ie, causal, modifiable factors), such as 
altruism and prosocial behaviour. This could include 
increased opportunities to elicit community support,51,52 
exercise,53 social activities,54 training in assertiveness and 
conflict resolution,55 and group interventions that provide 
support through peers.56
The inclusion of altruism in UK Government health 
messages has likely had a positive effect on wellbeing 
compared with compulsory orders to stay at home.14 Key 
research questions include “What positive mechanistically 
based psychological interventions can be developed for 
mental wellbeing derived from theories of altruism and 
prosocial behaviour?” and “What can be learned from the 
large-scale roll-out of volunteer-based psychological 
interventions that will optimise the benefits to individuals 
and society?”
Working from home, loss of employment, and social 
and physical distancing have abruptly interrupted many 
social opportunities important to physical and psycho-
logical health. It is important to research the mental 
health dimension of online life and investigate how 
changes in engagement with gaming and online 
platforms might inform interventions aimed at improving 
mental health. We must rapidly learn from successful 
existing strategies to maintain and build social resources 
and resilience and promote good mental health in specific 
populations moving forward.
Social and population factors: the effect of 
COVID-19 on mental health
Population-level factors, such as the effect of social 
distancing measures (more recently being redescribed as 
physical distancing)57 and other necessary public health 
measures, affect mental health within a syndemics 
approach (table 2). By syndemics we mean intersecting 
global trends among demographics (eg, ageing, rising 
inequality) and health conditions (eg, chronic diseases 
and obesity) that yield resultant comorbidities. These 
Immediate actions Longer-term strategic programmes
What are the mental health 
consequences of the 
COVID-19 lockdown and 
social isolation for vulnerable 
groups, and how can these be 
mitigated under pandemic 
conditions?
Determine the best ways of signposting and delivering 
mental health services for vulnerable groups, including 
online clinics and community support; identify and evaluate 
outreach methods to support those at risk of abuse within 
the home; ascertain which evidence-based interventions can 
be rapidly repurposed at scale for the COVID-19 pandemic, 
and identify intervention gaps requiring bespoke remotely 
delivered interventions to boost wellbeing and reduce 
mental health issues; swiftly provide interventions to 
promote mental wellbeing in front-line health-care workers 
exposed to stress and trauma that can be delivered now and 
at scale
On the basis of the intervention gaps identified, design 
bespoke approaches for population-level interventions 
targeted at the prevention and treatment of mental health 
symptoms (eg, anxiety) and at boosting coping and resilience 
(eg, exercise); develop innovative novel universal interventions 
on new mechanistically based targets from experimental and 
social sciences (eg, for loneliness consider befriending) that 
can help mental health; assess the effectiveness of arts-based 
and life-skills based interventions and other generative 
activities including exercise outdoors
What is the effect of repeated 
media consumption about 
COVID-19 in traditional and 
social media on mental 
health, and how can 
wellbeing be promoted?
Understand the role of repeated media consumption in 
amplifying distress and anxiety, and optimal patterns of 
consumption for wellbeing; develop strategies to prevent 
over-exposure to anxiety-provoking media, including how to 
encourage diverse populations to stay informed by 
authoritative sources they trust; mitigate and manage the 
effect of viewing distressing footage
Inform evidence-based media policy around pandemic 
reporting (eg, clearly identify authoritative sources, encourage 
companies to correct disinformation, and policies on traumatic 
footage); mitigate individuals’ risk of misinformation 
(eg, improve health literacy and critical thinking skills and 
minimise sharing of misinformation); understand and harness 
positive uses of traditional media, online gaming, and social 
media platforms
What are the best methods 
for promoting successful 
adherence to behavioural 
advice about COVID-19 while 
enabling mental wellbeing 
and minimising distress?
Understand how health messaging can optimise behaviour 
change, and reduce unintended mental health issues; track 
perceptions of and responses to public health messages to 
allow iterative improvements, informed by mental health 
science
Synthesise evidence base of lessons learned for future 
pandemics, tailored to specific groups as required; motivate 
and enable people to prepare psychologically and plan 
practically for possible future scenarios; understand the 
facilitators and barriers for activities that promote good 
mental health, such as exercise; promote people’s care and 
concern for others, fostering collective solidarity and altruism
COVID-19=coronavirus disease 2019.
Table 2: Social and population factors: the effect of COVID-19 on mental health
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interacting health effects and societal forces that fuel 
them combine to form syndemics, or complex knots 
of health determinants.58 Research priorities around 
COVID-19 require us to embrace complexity by deploying 
multidimensional perspectives.
What are the mental health consequences of the 
COVID-19 lockdown and social isolation for vulnerable 
groups, and how can these be mitigated under 
pandemic conditions? 
We do not yet know the acute or long-term con sequences 
of the COVID-19 lockdown and social isolation on mental 
health. Although worries and uncertainties about a 
pandemic are common, for some they can cause undue 
distress and impairment to social and occupational 
functioning.14,59,60 Across society, a sense of loss can stem 
from losing direct social contacts, and also range from loss 
of loved ones, to loss of employment, educational 
opportunities, recreation, freedoms, and supports. Existing 
evidence suggests some measures taken to control the 
pandemic might have a disproportionate effect on those 
most vulnerable (panel 2).
Vulnerable groups include those with pre-existing 
mental or physical health issues (including those with 
severe mental illnesses), recovered individuals, and those 
who become mentally unwell (eg, in response to anxiety 
and loneliness surrounding the pandemic; panel 2).14,61,62 
Therefore, loss of access to mental health support, 
alongside loss of positive activities, might increase 
vulnerability during COVID-19 lockdown. Increased 
feelings of anxiety and depression in response to the 
outbreak have been highlighted already.63 Health workers 
who come in close contact with the virus and are exposed 
to traumatic events, such as death and dying, while 
making highly challenging decisions, are particularly at 
risk of stress responses.15
The pandemic intersects with rising mental health 
issues in childhood and adolescence.2,64,65 Ascertaining and 
mitigating the effects of school closures for youth seeking 
care is urgent and essential, given that school is often the 
first place children and adolescents seek help,64,66 as is 
considering vulnerabilities, such as special educational 
needs and developmental disorders, and finding 
therapeutic levers.67 For the older population, promoting 
good mental health is important during self-isolation, 
which can be compounded by lifestyle restrictions, 
exacerbated loneliness, comorbidities (such as dementia), 
and feelings of worry and guilt for using resources.68 There 
is an acute need to identify, in consultation with people 
with lived experience, remotely delivered interventions 
that support those at risk of abuse.69,70
The immediate research priorities are to reduce mental 
health issues and support wellbeing in vulnerable groups 
in particular. A coordinating mechanism for pandemic 
mental health interventions is required for the agile 
identification of interventions that can be repurposed, 
alongside the identification of intervention gaps that will 
require bespoke de novo design, and the evaluation and 
roll-out of remotely delivered interventions. By the term 
intervention, we mean interventions of all sorts that 
make a difference to mental health, including population-
level policy, occupational guidelines, and psychological 
interventions.
We need to gather high-quality data rapidly to ascertain 
the effects of lockdown and social isolation over time. 
Innovative research is needed to establish ways to 
mitigate and manage mental health risks and inform 
interventions under pandemic conditions.
Research to support vulnerable groups needs to consider 
cross-cutting themes (such as the physical absence of 
schools and clinics) to create methods to provide con-
nectivity and support; promote rapid innovation in mental 
Panel 2: Populations of interest, including vulnerable groups
Although the whole population is affected by the coronavirus 
disease 2019 pandemic, specific sections of the population 
will experience it differently.
Children, young people, and families will be affected by 
school closures. They might also be affected by exposure to 
substance misuse, gambling, domestic violence and child 
maltreatment, absence of free school meals, accommodation 
issues and overcrowding, parental employment, and change 
and disruption of social networks.
Older adults and those with multimorbidities might be 
particularly affected by issues including isolation, loneliness, 
end of life care, and bereavement, which may be exacerbated 
by the so-called digital divide.
People with existing mental health issues, including those with 
severe mental illnesses, might be particularly affected by 
relapse, disruptions to services, isolation, the possible 
exacerbation of symptoms in response to pandemic-related 
information and behaviours, and changes in mental health law.
Front-line health-care workers might be affected by fears of 
contamination, moral injury, disruption of normal supportive 
structures, work stress, and retention issues.
People with learning difficulties and neurodevelopmental 
disorders might be affected by changes and disruption to 
support and routines, isolation, and loneliness.
Society might experience increased social cohesion and 
communitarianism, but also be negatively affected by 
increased health inequalities, increased food bank use, 
increased race-based attacks, and other trauma. Rural 
communities might also be affected differently to urban 
communities.
Socially excluded groups, including prisoners, the homeless, 
and refugees, might require a tailored response.
People on low incomes face job and financial insecurity, 
cramped housing, and poor access to the internet and 
technology.
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health services that can be remotely signposted and 
delivered (including online clinics and community 
support); identify and evaluate means to support those at 
risk of abuse within the home (eg, online outreach); and 
swiftly provide interventions to promote mental wellbeing 
in front-line health workers. By identifying cross-cutting 
research themes, interventions to help specific vulnerable 
populations should be leveraged to help other vulnerable 
groups.
With regard to the longer-term priorities, health services 
research must reliably and iteratively inform remotely 
delivered mental health resources, such as digital clinics, 
to efficiently manage mental health issues in an adaptive 
and flexible manner.71 This requires a coordinating 
mechanism to prioritise and streamline efforts, working 
with service users to optimise signposting and delivery 
and define therapeutic targets that matter from a user 
perspective (eg, loss, loneliness). Such a mechanism 
requires a range of disciplines, including psychology, 
digital science, and social sciences.31,72 International 
collaboration will ensure the necessary research skills and 
expertise. Research should harness internet-based social 
media and gaming using existing platforms and be 
cognisant of the so-called digital divide, which leaves 15% 
of Britons without internet access.73
Research for population-level interventions will require 
rapid evolution of approaches, starting with testing 
whether existing digital interventions can be repurposed, 
such as physical activity, sleep, and stress management 
programmes, as well as targeted approaches for the 
prevention and treatment of established mental health 
symptoms (eg, anxiety and worry).31,74 Tailoring of such 
universal interventions will need to be informed by 
exper imental and social science (eg, for loneliness, 
befriending, and physical activity).75,76 The effectiveness of 
arts-based interventions also needs to be assessed77 as do 
other generative activities that boost positive coping and 
resilience throughout society, from community-based 
activities, to life-skills classes, to exercising outdoors.4 The 
effectiveness of all interventions requires rigorous 
evaluation and implementation to avoid recommending a 
plethora of apps with no evidence base.78 Interventions at 
the population level should be repurposed, developed, 
and tested in a virtuous loop to create the necessary 
evidence base.
What is the effect of repeated media consumption about 
COVID-19 through traditional media and social media 
on mental health, and how can wellbeing be promoted?
People seek trusted information via the media, which can 
provide swift, critical guidance regarding the pandemic. 
Media consumption can be adaptive and positive for 
mental health. However, reports of infectious diseases 
often use risk-elevating messages, which can amplify 
public anxiety.79 Social media can be a source of rapidly 
disseminated misinformation,80 amplifying perceptions 
of risk.81 Repeated media exposure to information about 
an infectious disease particularly can exacerbate stress 
responses, amplify worry, and impair functioning.82 
Anxiety and uncertainty can drive additional media 
consumption and further distress, creating a cycle that 
can be difficult to break.83 Media-fuelled distress can 
promote behaviours that negatively affect the health-care 
system (eg, visits to emergency departments and hoarding 
of face masks), with downstream mental and physical 
health consequences.84
The immediate research priority is to better understand 
the role of repeated media consumption around 
COVID-19 in amplifying distress and mental ill-health in 
various groups, and the optimal patterns of consumption 
to promote wellbeing. Research is needed to inform 
future approaches, including strategies to help individuals 
to stay informed by authoritative sources, prevent over-
exposure to media, and mitigate and help manage the 
effect of viewing images with traumatic content.
Longer-term research priorities should inform evidence-
based guidelines for media around pandemic reporting 
(eg, clearly identifying authoritative sources, limiting 
graphic footage, and encouraging social media companies 
to flag or correct disinformation and rumours). Research 
should also help to develop strategies to mitigate an 
individual’s risk of exposure to misinformation and 
amplification of anxiety by minimising sharing of mis-
information, and promoting strategies for managing the 
emotional consequences. Adaptive and positive uses of 
traditional media and social media, such as influencers, 
should be understood and harnessed. Understanding the 
effect of pandemic media on various vulnerable groups is 
essential.
What are the best methods for promoting successful 
adherence to behavioural advice about COVID-19 while 
enabling mental wellbeing and minimising distress? 
Behavioural change—such as the three personal 
protective behaviours of handwashing, not touching the 
T-zone of the face, and tissue use, and social or physical 
distancing required to control the pandemic—
necessitates ensuring people know what to do, are 
motivated to do it, and have the skills and opportunity to 
enact the changed behaviours.85,86 Messaging is key for 
good knowledge,86 but public health messaging needs to 
draw on behavioural science if it is to be effective and 
avoid unintended consequences. We know that the more 
concerned people are in pandemics, the more likely they 
are to adhere to advice.59 However, increasing concern 
experienced by the public might heighten distress, 
which could undermine adherence or exacerbate existing 
mental health issues. Anxiety can be fuelled by 
uncertainty and by fears of risk of harm to self or others. 
For example, feelings of paranoia87 can be heavily 
influenced by anxiety, and symptoms of obsessive 
compulsive disorder88 can be associated with fear of 
contagion and rigid handwashing.89 Increasing people’s 
confidence and clarity in what they need to do fosters 
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adherence to health behaviours,90 and can help people to 
manage psychological distress.
Immediate research on COVID-19 health messaging is 
urgently required to both optimise health behaviour 
change and to reduce unintended mental health issues, 
which will be required in the event of a second wave of 
infection. Research should prioritise message content, 
format, and delivery modes and behavioural change 
alongside risk communication, and consider how this 
might need to vary for diverse groups. A virtuous cycle that 
tracks perceptions of and responses to public health 
messages during this pandemic will enable iterative 
improvements. It must be informed by mental health 
science3 to close the knowledge-to-implementation gap 
(eg, between effective behaviour messages and maladaptive 
consequences).
Longer-term research priorities are to create an 
evidence base of lessons learned to plan for future 
pandemics—that is, detailing how to foster a rapid and 
coordinated response regarding health messaging from 
governments91 and simultaneously to develop effective 
systems embedded in communities to reach out and 
access the most vulnerable groups in our society, 
including how to motivate and enable people to prepare 
psychologically and plan practically for possible future 
scenarios, and how to promote people’s care and concern 
for others, fostering a sense of collective solidarity and 
altruism. The optimal messaging should be tailored 
(including digitally) to different social groups to connect 
diverse segments of the population to appropriate mental 
health information resources.
Neuroscience: effects of the virus on brain 
health and mental health
Almost nothing is known with certainty about the effect of 
SARS-CoV-2 infection on the human nervous system. 
SARS-CoV-2 is a zoonotic virus and a review from 2005 
suggested that about half  of zoonotic virus epidemics 
have been caused by neurotropic viruses that invade the 
CNS.92 The closely related coronaviruses responsible for 
the severe acute respiratory syndrome epidemic in 2003 
and the so-called Middle East respiratory syndrome in 
2012 are biologically neurotropic and clinically neurotoxic, 
causing mental health and neurological disorders.93–95 
SARS-Cov-2 has a similar receptor-binding domain 
structure to SARS-CoV and probably shares its 
neurotropism and neurotoxicity (panel 3).96
Neurological symptoms of COVID-19 infection are 
common, diverse, and often severe. In a retrospective 
study of 214 patients in Wuhan, China 36% had CNS 
symptoms or disorders and the subgroup of 88 patients 
with severe respiratory disease had significantly increased 
frequency of CNS problems (45%).97 The problems 
reported include dizziness, head ache, loss of smell 
(anosmia), loss of taste (ageusia), muscle pain and 
weakness, impaired consciousness, and cerebrovascular 
complications. Similar reports have begun to emerge from 
Italy.98 Some of these acute neurological presentations 
could reflect systemic aspects of infection, such as 
disseminated intravascular coagulation causing strokes or 
intense inflammation and hypoxia causing delirium.
SARS-CoV-2 infection of the brain could be a 
contributor to the core medical syndrome of respiratory 
distress and failure in patients with COVID-19.99 Viral 
infection of the lung alveoli is the immediate cause of 
severe acute respiratory syndrome; but viral infection of 
key brainstem nuclei could disrupt the normal rhythms 
and homoeostatic control of respiration. This idea needs 
to be tested rapidly99 because if brainstem infection does 
contribute to the severity of SARS and the need for 
treatment in an intensive care unit, it could be directly 
relevant to the immediate COVID-19 crisis in the NHS 
and other health-care systems.
In the longer term, it is possible that SARS-CoV-2 will 
have persistent direct neurotoxic effects and immune-
mediated neurotoxic effects on the brain. The Spanish 
flu epidemic of 1918–19 was linked to a spike in incidence 
of post-encephalitic Parkinsonism.100 Currently, it is not 
known if SARS-CoV-2 infection could cause mental 
health or neurodegenerative disorders immediately or 
years after the acute respiratory phase of COVID-19 has 
passed, but action is needed now to build the research 
capacity to test these potentially important biological 
causes of COVID-19-related mental illness.
Immediate actions include the development of a 
neuropsychological database of COVID-19 cases to bring 
together standardised, longitudinally repeated data at 
scale both from the clinic for those needing hospital 
Panel 3: Neuroscience: effects of the virus on brain health 
and mental health
Immediate actions
• Build a neuropsychological database of UK coronavirus 
disease 2019 cases (standardised, longitudinally repeated, 
data at scale) which is clinically and geographically 
inclusive
• Expand facilities for severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) infected tissue handling
Longer-term strategic research programmes
• Understand how SARS-CoV-2 might enter and propagate 
through the brain and how the immune response to 
SARS-CoV-2 infection contributes to mental health and 
neurological symptoms
• Investigate the long-term relationship between 
SARS-CoV-2 infection and post-infective fatigue or 
depressive syndromes 
• Validate clinical biomarkers of SARS-CoV-2 brain infection 
using MRI and other methods
• Develop interventions to interrupt or prevent the adverse 
biological effects of SARS-CoV-2 on brain function and 
mental health, including repurposed drugs
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treatment and by online assessments for patients in 
isolation at home. Following the progression of clinical 
symptoms over time will be key to understanding and 
predicting the effects of infection on the CNS.
Facilities for SARS-CoV-2-infected tissue handling 
need to be expanded to examine human brain tissue post 
mortem, which is crucial to understanding the 
neurotropic and neurotoxic properties of the virus. 
Facilities equipped to safely handle human (or animal) 
brain tissue infected with SARS-CoV-2 are currently very 
few in number. We recommend building pathology and 
molecular neuroscience networks to enable brain and 
other tissue to be collected at autopsy and examined for 
viral infection and damage. This will require protocols 
for tissue collection and examination in appropriate 
laboratory facilities to protect researchers and other staff 
at all times.
The longer-term research priorities are to understand 
the mechanisms by which SARS-CoV-2 might enter the 
brain. There are two conceivable pathways: neuronal or 
vascular.101 The neuronal pathway, used by other corona-
viruses,102,103 is to invade a specialist sensory receptor in 
peripheral tissue, travel by the axonal transport systems to 
the brainstem, and propagate between neurons by trans-
synaptic mechanisms. It is not known whether 
SARS-CoV-2 can follow the same path to infect the human 
brain or whether it invades nerve cells by hijacking 
angiotensin converting enzyme 2 (ACE2),104–106 despite 
neurons expressing low amounts of the protein, as 
described in a preprint107 and two other published 
studies.108,109  Alternatively, SARS-CoV-2 might invade the 
brain from the blood, if circulating particles of the virus 
were transported across the blood–brain barrier by 
binding to ACE2 receptors expressed by endothelial 
cells,109 or if infected leucocytes could carry the virus with 
them as they migrate into the tissues as part of the 
immune response to infection.110 Better understanding of 
how the intense systemic immune response to 
SARS-CoV-2 infection affects mental health and 
neurological symptoms,97,111,112 and of the mechanisms of 
immune clearance of SARS-CoV-2, is also needed.113,114
Post-infectious fatigue and depressive syndromes have 
been associated with other epidemics, and it seems 
possible that the same will be true of the COVID-19 
pandemic. Longitudinal studies, especially if commenced 
before or soon after the start of the current pandemic, will 
be crucial in establishing the often complex biological 
pathways between infection and mental health 
outcomes.115–117
Candidate biomarkers need to be evaluated to measure 
the effects of SARS-CoV-2 infection on the human brain 
and brainstem in living patients, including structural 
and functional MRI, diffusion-weighted MRI, 
quantitative cerebral blood flow imaging, and magnetic 
resonance spectroscopy. The 7 Tesla MRI technique has 
sufficient spatial resolution to measure functional 
connectivity between subcortical structures that 
constitute networks for respiratory control and distress.118 
Other methods could include sampling cerebrospinal 
fluid or use of PET to measure brain inflammation; 
patient self-reporting or behavioural testing of smell, 
taste, and other cranial or vagal sensory functions; 
electrophysiological methods to measure brainstem 
function; and computerised tests of cognitive and 
emotional processing.
Informed by greater understanding of the effects of 
viral infection on the nervous system and by more 
accurate biomarkers of brain function in patients with 
COVID-19, interventions need to be developed to 
interrupt or prevent the adverse biological effects of 
SARS-CoV-2 on brain function and mental health. 
Potential drug targets include putative mechanisms for 
neuronal invasion, interneuronal propagation, and 
immune clearance of SARS-CoV-2. Biological and clinical 
validation of these or other targets would enable 
experimental medicine studies or early clinical trials of 
repurposed drugs. For example, the ACE2 inhibitors 
already licensed for treatment of hypertension, and a 
licensed drug for reflux oesophagitis, camostat mesylate, 
that blocks the serine protease TMPRSS2119 (which 
operates with ACE2 to facilitate viral entry into cells) 
have already been advocated as repurposable drugs. 
There are many other potential candidates for drug 
repurposing described in a preprint,120 which could be a 
faster route to effective treatment for CNS infection than 
development of entirely new drugs or vaccines. 
Partnerships between researchers in academia and 
industry will be vital.
Infrastructure and opportunities
Many of the immediate priorities are for surveillance of 
general and specific populations for effects of SARS-CoV-2 
infection on health, ranging from health behaviours, 
psychological symptoms, neuropsychiatric disorders, and 
mortality, including, but not limited to, suicide. The other 
immediate priority is to assemble cohorts to determine 
longer-term outcomes and provide a resource for nesting 
intervention studies, and a resource of interventions to 
monitor their effectiveness. We recommend three main 
routes. For each of these routes, there is a need to 
coordinate existing research infrastructure through 
shared protocols, research measures, and data assets, and 
to uphold the highest standards of scientific and ethical 
review. We urge the mental health science community to 
combine agility in initiating new or adapting existing 
research with collective scrutiny and collaboration.
First, administrative data assets principally derived 
from existing electronic health records, with systems in 
place to interrogate these for research purposes, provide 
a means of identifying health effects at scale. Health Data 
Research UK is coordinating national efforts. Examples 
include the Clinical Practice Research Database121 and 
similar primary care databases; the Clinical Record 
Interactive Search122 and other related systems for the 
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interrogation of mental health records; and CogStack123 
for general hospital settings, which provides near real-
time information from health records (eg, to provide 
feedback on neurological consequences of severe 
COVID-19). These systems should be linked between 
mental health services, acute medical services, and 
community health services to identify patterns and 
trends both in clinical populations and in individuals 
with confirmed or suspected COVID-19.
Second, surveillance through recruitment platforms 
and existing cohorts has the benefit of embedding 
research on COVID-19 into studies where participants’ 
mental or cognitive health has previously been 
ascertained. Existing cohorts or data platforms that can 
be rapidly deployed for COVID-19 research are likely to 
be particularly valuable. Examples include the National 
Institute for Health Research National Bioresource, a 
platform that already includes clinical and genetic data 
on participants, and could be deployed for rapid 
characterisation of mental health and neurological 
symptoms. UK Biobank has successfully done a web-
based mental health survey of 160 000 individuals, and 
the ongoing neuroimaging studies of 100 000 individuals 
with some repeat imaging, provide an ideal opportunity 
to image the effect of SARS-CoV-2 infection on the brain 
and the brainstem via a before-and-after imaging 
comparison.
Third, novel population-based studies on mental health 
and COVID-19 should be established, using appropriate 
epidemiologically robust survey methodology for both the 
whole population and specific groups of particular 
interest (eg, children and young people, front-line staff in 
health and social care, and people who have survived 
severe COVID-19). Priority should be given to assembling 
representive populations using explicit sampling frames. 
Finally, many other disciplines will be establishing similar 
studies and it is vital that the ascertainment of mental 
health should be embedded wherever possible.
Whether using established or new cohorts, priority 
should be given to methods that can ascertain COVID-19 
status, symptoms, and behaviours in as close to real-time 
as possible, providing a dynamic picture of change in 
illness status, social circumstances, and behaviours. 
Questions regarding COVID-19 and mental health 
symptoms and social stressors can readily be dis-
seminated through smartphones. Passive data from 
smartphones can also give high temporal resolution to 
behaviours related to the pandemic. Cohorts should gain 
permissions for the linkage of records, including 
serological status, when mass testing becomes available, 
and consent for recruitment into nested substudies, 
including randomised trials of interventions.
Patient and public involvement in research is a critical 
underpinning component to research. Given that the 
entire population has lived experience of the COVID-19 
pandemic, researchers will need to be particularly 
mindful of consulting and collaborating with patient and 
public groups that reflect the diverse groups being 
studied when developing protocols, conducting research, 
and interpreting results (panel 4).
Call for action
Multidisciplinary mental health science research must 
be central to the international response to the COVID-19 
Panel 4: Principles of good research practice in COVID-19 research
Study design
Researchers must continue to describe the patient group or population and the research 
question under study. A priori research questions are crucial. Sample size, sources of bias, 
participant characteristics (including sex, age, and ethnicity), and study design need to be 
carefully considered and must be appropriate to the research questions.
Ethics
Research on human participants should maintain high standards of ethical practice, 
including seeking research ethics committee approval.124 Committees now have fast-track 
procedures to expedite study start up. Ethical considerations for doing coronavirus 
disease 2019 (COVID-19)-related research have been published.125,126
Vulnerable groups
Researchers should recognise the capacity of the pandemic to exacerbate health 
inequalities within populations, particularly affecting people with established mental 
health issues (including severe mental illnesses) and physical disability. Those with 
precarious or no employment or housing, or other forms of social inequality, such as 
digital poverty,41 should also be considered.
Involvement of patients, people with lived experience, and the public
Researchers should continue to engage and involve patients, people with lived experience, 
the public, and service providers in their work by mutually setting research questions, 
testing the acceptability of protocols and questionnaires, and interpreting results. 
Researchers should ensure that they discuss their research findings with participants.
Harmonised data and measures
There is an obvious need for researchers to use and share full study protocols and 
measures, where possible. This will facilitate comparisons between data and projects. 
The urgency of the research effort should be a strong driver for the principles of open 
science, reproducibility, and data sharing. The ready availability of analysis code and data 
is essential to verifying findings. Broad adoption of the registered reports publication 
model,127 including rapid peer review of study protocols before data collection, will help to 
minimise waste and ensure conclusions are empirically sound.
Interdisciplinary working
The challenge of the COVID-19 pandemic requires imaginative collaborations between 
disciplines, including, but not limited to, psychology, psychiatry, neuroscience, virology, 
intensive care medicine, and respiratory medicine. Previous experience with epidemics 
has shown the “essential role that the humanities and social sciences play in information, 
reduction of fear and stigma, prevention, screening, treatment adherence, and control 
policies”.128
Collaboration and coordination
Where possible, research protocols should be deployed at scale harnessing existing 
research infrastructures, including the Clinical Research Networks, Biomedical Research 
Centres, Mental Health Translational Research Collaboration, MQ Data Science group, 
charities, service user groups, and professional bodies. To avoid waste and protect against 
participant fatigue, it is essential that there is national coordination across research 
groups. International collaboration and a global perspective would also be beneficial.
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pandemic, given the potential effects on individual and 
population mental health, and its potential effect on the 
brain function of some of those affected by the disease. 
There are important immediate insights to be gained, 
which could provide evidence-based guidance on 
responding to this pandemic and on how to promote 
mental health and wellbeing, and safeguard the brain, 
should future waves of infection emerge (panel 5).
The research priorities across the social, psychological, 
and neuroscientific aspects of this pandemic should be 
coordinated at a national and international level. We urge 
UK research funding agencies to work with researchers, 
people with lived experience, and others to establish a 
high-level coordination group to ensure that the mental 
health science research priorities are addressed swiftly, 
and that a firm evidence base is established for long-term 
studies. We need rigorous, peer-reviewed, ethically 
approved research codeveloped with people with lived 
experience that can be translated into effective inter-
ventions, rather than the current uncoordinated approach 
with a plethora of underpowered studies and surveys.
The immediate priority is the collection of high-quality 
data on the mental health and psychological effects of the 
COVID-19 pandemic across the whole population and in 
specific vulnerable groups, and on brain function, 
cognition, and mental health for patients with COVID-19 
at all clinical stages of infection and illness. These 
datasets must be brought together under a national data 
portal for rapid access and use.
There is an urgent need for the discovery, evaluation, 
and refinement of mechanistically driven interventions to 
address the psychological, social, and neuroscientific 
aspects of this pandemic. This includes bespoke 
psychological interventions to boost wellbeing and 
minimise mental health risks across society, including in 
vulnerable groups, and experimental medicine studies to 
validate clinical biomarkers and repurpose new treat-
ments for the potentially neurotoxic effects of the virus. 
There is an urgent need for research to address the effect 
of repeated pandemic-related media consumption and to 
optimise health messaging around COVID-19. Rising to 
this challenge will require integration across disciplines 
and sectors, including industry and health and social care.
New funding will be required to meet these priorities, 
and it can be efficiently leveraged by the UK’s world-
leading neuroscience and mental health research 
infrastructure. The UK must connect with international 
funders and researchers to support a global response to 
the mental health and neurological challenges of this 
pandemic. In these challenging times, mental health 
science should be harnessed to serve society and benefit 
both mental and physical health in the long term.
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